Haloperidol DM&D Under review
Metadata
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2023 1.1.0
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/haloperidol-dmd
- Version ID
- 5393839e
About
Description
This code list includes all formulations of haloperidol, except for long acting depot formulations of haloperidol decanoate. Haloperidol is a first generation antipsychotic and a potent dopamine antagonist. It is licensed for a wide range of indications including the treatment of psychotic disorders, management of behavioral and psychiatric symptoms of dementia, acute delirium, chorea and tics, nausea and vomiting in post operative or palliative care and restlessness and confusion in palliative care.
Methodology
This list was developed using the available formulations for Haloperidol described in Chapter 4.2 of the BNF. Formulations that contained Haloperidol decanoate were not included. Formulations that included Haloperidol acetate were included.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_id | type | name | bnf_code |
|---|
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.